Menu

Therapeutic Areas

 

Eligibility criteria in clinical trials - image of patient in hospital bed

Eligibility criteria in clinical trials

Giovanni Monopoli, senior project manager, reflects on what he learned about the eligibility criteria at an American Society of Clinical Oncology (ASCO) conference presentation in 2017.

Read more...
 

Woman with cancer and child - The challenges of immuno-oncology combined clinical development, Part IV

The challenges of immuno-oncology combined clinical development, Part IV

In the final of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Cancer patient The challenges of immuno-oncology combined clinical development, Part III

The challenges of immuno-oncology clinical development, Part III

In the third of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Cancer patient with medical professional for the challenges of combination therapies in immuno-oncology clinical development

The challenges of immuno-oncology clinical development, Part II

In the second of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Challenges of immuno-oncology clinical development

The challenges of immuno-oncology clinical development, Part I

In the first of a four-part series, Jai Balkissoon, vice president of global product development, writes about the increase in immuno-oncology therapies.

Read more...
Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.